Renal Replacement Therapy for Cardiogenic Shock
(OFFLOAD-SHOCK Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
CAPITAL OFFLOAD-SHOCK will aim to answer if early use of renal replacement therapy, like dialysis, in patients with reduced body fluids causing the heart to be unable to pump enough blood through the body reduces in-hospital death when compared to the current standard of care. The current standard of care is to wait until renal replacement therapy is clinically necessary.
Who Is on the Research Team?
Simon Parlow, MD, FRCPC
Principal Investigator
Ottawa Heart Institute Research Corporation
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants receive renal replacement therapy within 2-6 hours of randomization.
Participants will receive the standard of care medical therapy with discouragement of renal replacement therapy unless medically necessary.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ottawa Heart Institute Research Corporation
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.